Eledon Pharmaceuticals (ELDN) Change in Cash (2016 - 2017)
Historic Change in Cash for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to -$3.4 million.
- Eledon Pharmaceuticals' Change in Cash fell 33581.78% to -$3.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was $16.8 million, marking a year-over-year increase of 27002.43%. This contributed to the annual value of $15.9 million for FY2024, which is 13076.82% up from last year.
- According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Change in Cash is -$3.4 million, which was down 33581.78% from $21.9 million recorded in Q2 2017.
- Over the past 5 years, Eledon Pharmaceuticals' Change in Cash peaked at $84.3 million during Q3 2014, and registered a low of -$35.1 million during Q2 2015.
- In the last 5 years, Eledon Pharmaceuticals' Change in Cash had a median value of -$2.3 million in 2016 and averaged $1.1 million.
- In the last 5 years, Eledon Pharmaceuticals' Change in Cash tumbled by 429663.46% in 2015 and then skyrocketed by 19075.25% in 2017.
- Eledon Pharmaceuticals' Change in Cash (Quarter) stood at $8.6 million in 2013, then plummeted by 102.41% to -$208000.0 in 2014, then plummeted by 4296.63% to -$9.1 million in 2015, then skyrocketed by 86.12% to -$1.3 million in 2016, then crashed by 169.27% to -$3.4 million in 2017.
- Its Change in Cash was -$3.4 million in Q3 2017, compared to $21.9 million in Q2 2017 and -$482000.0 in Q1 2017.